Is Turning Point Therapeutics Inc (TPTX) Stock Worth a Buy Thursday?

Thursday, May 12, 2022 02:45 PM | InvestorsObserver Analysts

Mentioned in this article

Is Turning Point Therapeutics Inc (TPTX) Stock Worth a Buy Thursday?

Turning Point Therapeutics Inc (TPTX) stock has fallen -57.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TPTX stock a score of 34 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 7. TPTX's rank also includes a short-term technical score of 10. The fundamental score for TPTX is 84. In addition to the average rating from Wall Street analysts, TPTX stock has a mean target price of $114.33. This means analysts expect the stock to gain 305.44% over the next 12 months.

TPTX has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on TPTX!

See Full TPTX Report

What's Happening with TPTX Stock Today

Turning Point Therapeutics Inc (TPTX) stock has gained 10.59% while the S&P 500 has fallen -1.73% as of 2:27 PM on Thursday, May 12. TPTX has gained $2.70 from the previous closing price of $25.50 on volume of 372,950 shares. Over the past year the S&P 500 has fallen -4.82% while TPTX has fallen -57.23%. TPTX lost -$5.57 per share in the over the last 12 months. Click Here to get the full Stock Report for Turning Point Therapeutics Inc stock.